Online first
Short communication
Published online: 2024-08-28
Low-grade lipopolysaccharide-related endotoxemia alters coronary thrombus composition and fibrin clot properties in patients with acute ST-segment elevation myocardial infarction
Pubmed: 39240915
Abstract
Not available
References
- Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction . Eur Heart J. 2019; 40(3): 237–269.
- Alkarithi G, Duval C, Shi Y, et al. Thrombus structural composition in cardiovascular disease. Arterioscler Thromb Vasc Biol. 2021; 41(9): 2370–2383.
- Ząbczyk M, Ariëns RAS, Undas A. Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice. Cardiovasc Res. 2023; 119(1): 94–111.
- Carnevale R, Sciarretta S, Valenti V, et al. Low-grade endotoxaemia enhances artery thrombus growth via Toll-like receptor 4: Implication for myocardial infarction. Eur Heart J. 2020; 41(33): 3156–3165.
- Violi F, Nocella C, Bartimoccia S, et al. Gut dysbiosis-derived low-grade endotoxemia: A common basis for liver and cardiovascular disease. Kardiol Pol. 2023; 81(6): 563–571.
- Vaure C, Liu Y. A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front Immunol. 2014; 5: 316.
- Sadowski M, Ząbczyk M, Undas A. Coronary thrombus composition: links with inflammation, platelet and endothelial markers. Atherosclerosis. 2014; 237(2): 555–561.
- Zalewski J, Bogaert J, Sadowski M, et al. Plasma fibrin clot phenotype independently affects intracoronary thrombus ultrastructure in patients with acute myocardial infarction. Thromb Haemost. 2015; 113(6): 1258–1269.
- Violi F, Cammisotto V, Bartimoccia S, et al. Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease. Nat Rev Cardiol. 2023; 20(1): 24–37.
- Nunes JM, Fillis T, Page MJ, et al. Gingipain R1 and lipopolysaccharide from have major effects on blood clot morphology and mechanics. Front Immunol. 2020; 11: 1551.
- Ząbczyk M, Kruk A, Natorska J, et al. Low-grade endotoxemia in acute pulmonary embolism: Links with prothrombotic plasma fibrin clot phenotype. Thromb Res. 2023; 232: 70–76.
- Sadowski M, Ząbczyk M, Undas A. Impaired fibrinolysis in patients with atrial fibrillation and elevated circulating lipopolysaccharide. J Thromb Thrombolysis. 2024; 57(5): 842–851.
- Carlin S, de Vries TAC, Budaj A, et al. Dual pathway inhibition for atherosclerotic cardiovascular disease: Recent advances. Kardiol Pol. 2022; 80(12): 1200–1210.
- Loffredo L, Ivanov V, Ciobanu N, et al. Low-grade endotoxemia and NOX2 in patients with coronary microvascular angina. Kardiol Pol. 2022; 80(9): 911–918.
